doxifluridine has been researched along with Thrombopenia in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (40.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fujitani, K; Furukawa, H; Goto, M; Imamoto, H; Imamura, H; Imano, M; Ishida, H; Kimura, Y; Narahara, H; Shimokawa, T; Takiuchi, H | 1 |
Abele, R; Alberto, P; Bollag, W; Germano, G; Heintz, R; Seematter, RJ | 1 |
Abele, R; Alberto, P; Cavalli, F; Hartmann, D; Hofmann, V; Holdener, EE; Kaplan, S; Ryssel, HJ; Siegenthaler, P | 1 |
Cho, JH; Kim, NK; Min, JS; Seong, J; Suh, CO | 1 |
Alberto, P; Mermillod, B; Winkelmann, JJ | 1 |
2 trial(s) available for doxifluridine and Thrombopenia
Article | Year |
---|---|
Multi-center phase II study for combination therapy with paclitaxel/doxifluridine to treat advanced/recurrent gastric cancer showing resistance to S-1 (OGSG 0302).
Topics: Adenocarcinoma; Aged; Anemia; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Drug Combinations; Drug Resistance, Neoplasm; Female; Floxuridine; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Oxonic Acid; Paclitaxel; Peritoneal Neoplasms; Stomach Neoplasms; Survival Rate; Tegafur; Thrombocytopenia | 2008 |
Preoperative chemoradiotherapy with oral doxifluridine plus low-dose oral leucovorin in unresectable primary rectal cancer.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Diarrhea; Female; Floxuridine; Humans; Leucovorin; Male; Middle Aged; Preoperative Care; Radiotherapy; Rectal Neoplasms; Thrombocytopenia | 2001 |
3 other study(ies) available for doxifluridine and Thrombopenia
Article | Year |
---|---|
Phase I clinical study with 5'-deoxy-5-fluorouridine, a new fluoropyrimidine derivative.
Topics: Adult; Aged; Agranulocytosis; Antineoplastic Agents; Drug Administration Schedule; Drug Evaluation; Female; Floxuridine; Half-Life; Humans; Kinetics; Leukocyte Count; Leukopenia; Male; Middle Aged; Neoplasms; Platelet Count; Stomatitis; Thrombocytopenia | 1982 |
Phase II study of doxifluridine in advanced colorectal adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Chemical Phenomena; Chemistry; Colonic Neoplasms; Drug Eruptions; Drug Evaluation; Female; Floxuridine; Heart; Humans; Leukopenia; Male; Middle Aged; Nausea; Rectal Neoplasms; Thrombocytopenia; Vomiting | 1983 |
[Doxifluridine toxicity, a fluorouracil analog with low myelosuppressive effect].
Topics: Administration, Oral; Antineoplastic Agents; Bone Marrow; Central Nervous System; Floxuridine; Heart; Humans; Infusions, Intravenous; Leukopenia; Thrombocytopenia | 1990 |